Archives: Search / 2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015
2014 Archives
Philadelphia, PA – May 5, 2014 – Lannett Company, Inc. (NYSE: LCI) today announced that the company’s president and chief executive officer, Arthur Bedrosian and chief financial... More |
Philadelphia, PA – April 29, 2014 – Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2014 third quarter on Wednesday, May 7, 2014... More |
Philadelphia, PA – April 15, 2014 – Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated... More |
Philadelphia, PA – March 27, 2014 – Lannett Company, Inc. (NYSE: LCI) today announced that the company’s president and chief executive officer, Arthur Bedrosian and chief financial... More |
Philadelphia, PA – March 6, 2014 – Lannett Company, Inc. (NYSE: LCI) today announced that the company’s president and chief executive officer, Arthur Bedrosian, chief financial... More |
Net Sales of $67 Million, Gross Margin of 61%, EPS of $0.46 - All the Highest in Company History; Fiscal 2014 Guidance Revised Upward Philadelphia, PA – February 6, 2014 – Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2014 second quarter and six months ended December 31, 2013. For... More |
Philadelphia, PA – February 4, 2014 – Lannett Company, Inc. (NYSE: LCI) today announced that the company’s president and chief executive officer, Arthur Bedrosian, and chief... More |
Philadelphia, PA – January 29, 2014 – Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2014 second quarter on Thursday, February... More |
| 1-25 26-33 |